Microfactory has just completed the first part of its in vivo/in vitro correlation on antiperspirant efficiency evaluations.
The SOD4 technology characterised the efficacy of 5 antiperspirants in a single blind study. In association with a Parisian CRO, these predictions were confirmed by gravimetry, the current method of in vivo testing.
Our technology measures the pressure required to expel the clots formed during the sweat/antiperspirant contact in the microfluidic synthetic pores.
The results of the in vivo and in vitro tests are consistent, SOD4 represents a predictive and economical alternative to human antiperspirant efficacy evaluations.
Read the complete article: ZOOM#17 -Testing trends nails evaluation – in vitro efficacy testing – Skinobs.web
Fabrice Monti, PhD
11 rue Vauquelin Angle Rue Lagarde/Rue Vauquelin
75005 Paris
Tél: + 33 (0) 6 62 72 04 61
Kristel Adriaenssens Milet 1 April 2025 Social intelligence company Dynvibe, which specialises in behavioural marketing…
26 March 2025 The 35th IFSCC Congress will take place in Cannes from September 15…
This AI-powered skin diagnostic device uses bio-optical technology alongside AI algorithms to analyze the skin’s…